These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25780066)

  • 21. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
    Kagami S; Kaneko M; Kishi A; Katori T
    J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
    Kagami S; Katori T
    J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
    El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P
    Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
    Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
    J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of infantile hemangiomas.
    Püttgen KB
    Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on infantile hemangiomas.
    Lee KC; Bercovitch L
    Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse neonatal hemangiomatosis in a very low-birthweight infant treated with erythropoietin.
    Okuno T; Tokuriki S; Yoshino T; Tanaka N; Ohshima Y
    Pediatr Int; 2015 Apr; 57(2):e34-6. PubMed ID: 25868957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
    Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary results of propranolol treatment for patients with infantile hemangioma.
    Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
    Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function.
    Tan ST; Itinteang T; Leadbitter P
    Pediatrics; 2011 Mar; 127(3):e772-6. PubMed ID: 21357335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence rate of infantile hemangioma after oral propranolol therapy.
    Frongia G; Byeon JO; Mehrabi A; Günther P
    Eur J Pediatr; 2021 Feb; 180(2):585-590. PubMed ID: 33188478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM; de Graaf M; Breugem CC; Pasmans SG
    Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
    Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
    J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature.
    Nord KM; Kandel J; Lefkowitch JH; Lobritto SJ; Morel KD; North PE; Garzon MC
    Pediatrics; 2006 Sep; 118(3):e907-13. PubMed ID: 16880251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late rebound of infantile hemangioma after cessation of oral propranolol.
    Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
    Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current trends in medical management of infantile hemangioma.
    Ames JA; Sykes JM
    Curr Opin Otolaryngol Head Neck Surg; 2015 Aug; 23(4):286-91. PubMed ID: 26101875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propranolol for severe infantile hemangiomas: follow-up report.
    Sans V; de la Roque ED; Berge J; Grenier N; Boralevi F; Mazereeuw-Hautier J; Lipsker D; Dupuis E; Ezzedine K; Vergnes P; Taïeb A; Léauté-Labrèze C
    Pediatrics; 2009 Sep; 124(3):e423-31. PubMed ID: 19706583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.